UNSPSC 51442305: Indium in 111 pentetreotide or indium (111in) pentetreotide

This classification denotes a radioconjugate with the molecular formula C63H83N13O19S2.H+.IN (a diethylenetriaminopentaacetic (DTPA) conjugate of the human hormone somatostatin peptide analogue [octreotide]), a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M312JJ6Z32, a preparation that World Health Organization schedules in its Anatomical Therapeutic Chemical (ATC) Classification. Indium in 111 satumomab pendetide bears US NLM NCI C1672.

UNSPSC 51442305 Indium in 111 pentetreotide or indium (111in) pentetreotide is a Commodity code representing radioactive diagnostic imaging agents used in nuclear medicine procedures. State and local governments procure this agent primarily through health departments, county corrections systems, and hospital networks for patient diagnostic imaging. Recent solicitations show demand concentrated in radiology departments and correctional facility medical operations, where the agent supports specialized diagnostic protocols.

The recent opportunities block shows minimal direct procurement activity under this code's nominal scope. Of four recent state and local opportunities posted between June and October 2026, only one — Escambia County Correction's August 2026 solicitation (SSCORALM2526005, due August 19) for an extended warranty on X-ray equipment — touches radiological equipment broadly, though it addresses warranty maintenance rather than the radiopharmaceutical itself. The remaining three opportunities address unrelated commodities: Maricopa County's October 2026 radiologic equipment installation (IFB362910, due October 22), Broward County Aviation's June 2026 RFI for Rapiscan X-ray system maintenance (BLD2132311F1, due July 28), and Pasco County's June 2026 copper sulfate procurement (RFQFP261004, due June 26). Geographic activity appears fragmented across Florida (Escambia, Broward, Pasco counties) and Arizona (Maricopa County), with no clear repeat buyers or concentrated procurement patterns. The code shows little relevant recent activity aligned with its intended scope of radiopharmaceutical supply.